Patrick Fiatarone is a Clinical Research Lead at Eli Lilly, primarily focused on oncology and neuroscience. This role supports planning and execution of Phase II and III clinical trial programs across Australia. He is a member of the Australian Teletrial Program Sponsors Advisory Board, contributing to the advancement of decentralised and remote trial delivery models across Australia.